These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 31220328

  • 21. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol.
    Criado PR, de Souza EspinelI DP, Valentef NS, Alavi A, Kirsner RS.
    Dermatol Ther; 2015; 28(4):248-53. PubMed ID: 25824252
    [Abstract] [Full Text] [Related]

  • 22. Painful Lower Extremity Ulcerations with Hyperpigmentation.
    Kumetz EA, Logemann NF, Rivard SC.
    Am Fam Physician; 2020 Feb 01; 101(3):177-178. PubMed ID: 32003956
    [No Abstract] [Full Text] [Related]

  • 23. Occlusive cutaneous vasculopathies as cause of chronic ulcers.
    Ronicke M, Berking C, Erfurt-Berge C.
    J Dtsch Dermatol Ges; 2024 Apr 01; 22(4):553-567. PubMed ID: 38379266
    [Abstract] [Full Text] [Related]

  • 24. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M, Miyamoto J, Nagasaka T, Chen KR.
    Am J Dermatopathol; 2009 May 01; 31(3):293-6. PubMed ID: 19384073
    [Abstract] [Full Text] [Related]

  • 25. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
    Criado PR, Alavi A, Halpern I, Sotto MN, Kirsner RS.
    Int J Low Extrem Wounds; 2013 Dec 01; 12(4):306-9. PubMed ID: 24043683
    [Abstract] [Full Text] [Related]

  • 26. [Vasculitis and vasculopathy].
    Marković A.
    Acta Med Croatica; 2012 Oct 01; 66 Suppl 1():19-24. PubMed ID: 23193816
    [Abstract] [Full Text] [Related]

  • 27. Livedoid Vasculopathy Associated with HIV Infection in Two Patients: A Causal Relationship?
    Hurabielle C, Sebille G, Barrou B, Moguelet P, Francès C, Barete S.
    Acta Derm Venereol; 2016 Aug 23; 96(6):844-5. PubMed ID: 26778817
    [No Abstract] [Full Text] [Related]

  • 28. Vascular ulcers in scleroderma.
    Thomas JR, Winkelmann RK.
    Arch Dermatol; 1983 Oct 23; 119(10):803-7. PubMed ID: 6137196
    [Abstract] [Full Text] [Related]

  • 29. Dermoscopy of early non-ulcerated livedoid vasculopathy.
    Wollina U.
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Sep 23; 27(3):147-148. PubMed ID: 30244265
    [Abstract] [Full Text] [Related]

  • 30. Livedoid vasculopathy: clinical features and treatment in 24 Chinese patients.
    Feng S, Su W, Jin P, Shao C.
    Acta Derm Venereol; 2014 Sep 23; 94(5):574-8. PubMed ID: 24352295
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
    Furukawa F, Mizawa M, Makino T, Shimizu T.
    BMJ Case Rep; 2017 Jul 24; 2017():. PubMed ID: 28739563
    [Abstract] [Full Text] [Related]

  • 32. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
    Sopeña B, Pérez-Rodríguez MT, Rivera A, Ortiz-Rey JA, Lamas J, Freire-Dapena MC.
    Lupus; 2010 Oct 24; 19(11):1340-3. PubMed ID: 20659971
    [Abstract] [Full Text] [Related]

  • 33. Livedo reticularis with ulcerations.
    FELDAKER M, HINES EA, KIERLAND RR.
    Circulation; 1956 Feb 24; 13(2):196-216. PubMed ID: 13356380
    [No Abstract] [Full Text] [Related]

  • 34. Livedo reticularis.
    Rose AE, Sagger V, Boyd KP, Patel RR, McLellan B.
    Dermatol Online J; 2013 Dec 16; 19(12):20705. PubMed ID: 24364996
    [Abstract] [Full Text] [Related]

  • 35. Livedo reticularis with summer ulcerations.
    FELDAKER M, HINES EA, KIERLAND RR.
    AMA Arch Derm; 1955 Jul 16; 72(1):31-42. PubMed ID: 14387292
    [No Abstract] [Full Text] [Related]

  • 36. Livedoid vasculopathy as a marker of systemic disease: report of two cases.
    Lima RS, Maquiné GÁ, Talhari C, Encarnação IC, Schettini AP, Santos M.
    An Bras Dermatol; 2014 Jul 16; 89(5):822-4. PubMed ID: 25184928
    [Abstract] [Full Text] [Related]

  • 37. Livedoid vasculopathy successfully treated with hyperbaric oxygen.
    Banham ND.
    Diving Hyperb Med; 2013 Mar 16; 43(1):35-6. PubMed ID: 23508660
    [Abstract] [Full Text] [Related]

  • 38. The potential role of tumor necrosis factor-α in thrombosis in livedoid vasculopathy.
    Qi F, Jin H.
    Arch Dermatol Res; 2024 Apr 18; 316(5):124. PubMed ID: 38637417
    [No Abstract] [Full Text] [Related]

  • 39. Quality-of-life impairment in patients with livedoid vasculopathy.
    Polo Gascón MR, de Carvalho JF, de Souza Espinel DP, Barros AM, Alavi A, Criado PR.
    J Am Acad Dermatol; 2014 Nov 18; 71(5):1024-6. PubMed ID: 25437971
    [No Abstract] [Full Text] [Related]

  • 40. Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy.
    Alix JJ, Hadjivassiliou M, Ali R, Slater D, Messenger AG, Rao DG.
    Muscle Nerve; 2015 Feb 18; 51(2):296-301. PubMed ID: 25196820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.